August 14, 2024 Experience Cheney Brothers $2.1 billion acquisition by Performance Food Group We are advising Cheney Brothers on the transaction
August 14, 2024 Experience Life Time $300 million follow-on offering The shares are listed on the New York Stock Exchange
August 13, 2024 Experience ANI Pharmaceuticals $316.25 million convertible notes offering We advised ANI Pharmaceuticals on the offering
August 13, 2024 Experience Penumbra $100 million accelerated share repurchase We advised Penumbra on the ASR transaction
August 12, 2024 Experience Alkami Technology $155.9 million secondary offering The shares are listed on the Nasdaq Global Select Market
August 12, 2024 Experience Fiserv $1.75 billion notes offering The investment-grade debt consists of two tranches of notes
August 12, 2024 Experience Enova International $500 million notes offering and concurrent tender offer The high-yield notes are due 2029
August 9, 2024 Experience Walgreens Boots Alliance $750 million notes offering We advised Walgreens Boots Alliance on its debt offering
August 9, 2024 Experience Ninth Circuit affirms dismissal for Lucid Motors, limits Section 10(b) standing We secured a complete victory for Lucid
August 9, 2024 Experience CytomX Therapeutics $58.3 million at-the-market offering The shares are listed on the Nasdaq Global Select Market